Conditional relative survival after gastric cancer surgery shows promising results, suggesting better outcomes than previously thought. Five-year conditional relative survival (CRS) rose from 87.2% at one year to 95.4% at five years post-surgery. Stage III patients saw significant improvement, with CRS increasing from 53.2% at one year to 85.2% at five years. Surgery remains a […]
Category: Upper Gastrointestinal Tract
Predicting Postoperative Leakage in Gastrectomy with AI
This study shows that deep learning can predict leakage during laparoscopic gastrectomy for gastric cancer, improving surgical outcomes. Leakage rates were 1.3% at the duodenal stump and 4.3% at the esophagojejunal anastomoses. The ResNet18 model achieved a recall of 84.7% for stump leakage and 80% for anastomosis leakage when trained on high-quality, single-image datasets with […]
ICG imaging elevates surgical outcomes in gastric cancer
Indocyanine green (ICG) guidance improves lymphadenectomy in gastric cancer post-neoadjuvant chemotherapy. ICG increased lymph node retrieval by an average of nearly 9 nodes. Patients with ICG guidance were 2.3 times more likely to retrieve 30 or more nodes compared to conventional methods. ICG use showed no increase in complications, supporting its safe application in surgical […]
Infectious Complications Skyrocket Post-Gastric and Colorectal Surgeries
Postoperative infections in gastric and colorectal cancer surgeries significantly increase costs and hospital stays, demanding urgent attention. 11.8% of surgeries resulted in infections, with 2.2% classified as major. Major infections lead to double the hospitalization costs and triple the length of stay. Surgeons should prioritize prevention strategies for intra-abdominal infections as key risk factors include […]
Predictive Modeling Revolutionizes Post-Gastrectomy Outcomes
Machine learning models effectively predict 30-day mortality after gastrectomy, enhancing surgical decision-making. 4.3% of gastrectomy patients experienced 30-day mortality. The xgboost model outperformed logistic regression and traditional risk calculators, identifying preoperative blood urea nitrogen and age as key predictors. Incorporating these models could significantly improve patient selection and care strategies in your practice. The xgboost […]
Rising Rates of Gastric Neuroendocrine Tumors Change Surgical Care
Gastric neuroendocrine neoplasms are on the rise, necessitating improved prognostic tools for better surgical outcomes. Incidence increased 16-fold over 46 years, from 0.435 to 7.033 per 1,000,000 people. A newly developed nomogram showed superior predictive accuracy (c-index of 0.86) compared to the AJCC staging system. Understanding these risk factors—age, sex, tumor characteristics, and surgical intervention—can […]
Spleen Preservation Cuts Complications in Total Gastrectomy
Spleen-preserving gastrectomy lowers complication rates in proximal gastric cancer. Reduced pancreatic fistula risk (RR 0.30; p < 0.000001) Less blood loss (MD -172.47; p = 0.012396) This approach supports safer patient outcomes when oncologic safety is prioritized. Lower risk of anastomotic leak (RR 0.51; p = 0.006769) and intra-abdominal abscess (RR 0.40; p = 0.000160) […]
Survival Gains with FLOT in cT2cN0 Esophageal Cancer
FLOT chemotherapy significantly improves survival in patients with cT2cN0 adenocarcinoma of the esophagus compared to chemoradiotherapy. Mean survival: 100.8 months for FLOT vs. 74.6 months for CROSS (p = 0.028). Three-year survival rates: 87% for FLOT vs. 59% for CROSS. Surgeons should prioritize FLOT treatment in multimodal approaches for these patients to enhance outcomes. 23.3% […]
Robotic Gastrectomy Enhances Outcomes in Locally Advanced Cancer
Robotic gastrectomy significantly improves surgical and survival outcomes for patients with locally advanced gastric cancer. 47.6% of robotic gastrectomy patients achieved textbook oncological outcomes, compared to 32.5% for laparoscopic. No severe complications in 98.4% of robotic cases vs. 89.7% for laparoscopic (p=0.006). 3-year overall survival rates were 86.2% for those achieving outcomes versus 65.5% for […]
Predicting outcomes in oesophagogastric junction cancer
Unexpected horizontal tumor spread significantly impacts outcomes for patients with oesophagogastric junction (OGJ) cancer, influencing surgical decisions. Patients with long pathological margins (δpm > 8mm) and long distal margins (δdm > 3mm) faced worse recurrence-free survival (RFS) and overall survival (OS). The long margin group was identified as an independent risk factor for poor RFS […]